|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 11/13/02 Sanofi 6-K 11/13/02 1:19K Cleary Gottlieb Ste… LLP |
Document/Exhibit Description Pages Size 1: 6-K Report of a Foreign Private Issuer HTML 15K
| Sanofi |
For the Month of
November 2002
SANOFI-SYNTHELABO
(Exact name of
registrant as specified in its charter)
174, avenue de France,
75013 Paris, FRANCE
(Address of principal
executive offices)
| (Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.) |
Form 20-F X Form 40-F
| (Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. |
Yes No X
| (If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-_______________. |
Paris, November 8, 2002
Dear Madam, Dear Sir,
Please find below the estimated dates for key financial announcements in 2003 :
Wednesday, January 22, 2003 
2002 sales press release Tuesday, February 18, 2003 2002 results press release Thursday, April 24, 2003 1st quarter 2003 sales press release Monday, May 19, 2003 Shareholders General Meeting Wednesday, July 23, 2003 1st half 2003 sales press release Tuesday, September 2, 2003 1st half 2003 results press release Wednesday October 22, 2003 9 months 2003 sales press release Yours sincerely,
Philippe Goupit
Investor Relations Department
Philippe Goupit Director of Investor Relations Isabelle Laurent Investor Relations Europe Sanjay Gupta Investor Relations US Contacts:
E-mail: investor-relations@sanofi-synthelabo.com
Europe US Tel: + 33 1 53 77 45 45 Tel.: 1 212 551 42 93 Fax: + 33 1 53 77 42 96 Fax: 1 212 551 49 10
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: November 13, 2002
| SANOFI-SYNTHELABO By: /s/ Marie-Helene Laimay Name: Marie-Helene Laimay Title: Senior Vice President and Chief Financial Officer |
| This ‘6-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| 10/22/03 | 6-K | |||
| 9/2/03 | 6-K | |||
| 7/23/03 | 6-K | |||
| 5/19/03 | ||||
| 4/24/03 | 6-K | |||
| 2/18/03 | 6-K | |||
| 1/22/03 | 6-K | |||
| Filed on / For Period End: | 11/13/02 | |||
| 11/8/02 | ||||
| List all Filings | ||||